Holen Sie sich die Stockscreener-App
10.52
0.47%
-0.06
Schlusskurs vom Vortag:
$10.58
Offen:
$10.65
24-Stunden-Volumen:
174.20K
Relative Volume:
0.11
Marktkapitalisierung:
$1.69B
Einnahmen:
$405.76M
Nettoeinkommen (Verlust:
$7.98M
KGV:
210.40
EPS:
0.05
Netto-Cashflow:
$77.47M
1W Leistung:
-2.86%
1M Leistung:
+6.80%
6M Leistung:
-11.59%
1J Leistung:
-8.12%
1-Tages-Spanne:
$10.52
$10.75
1-Wochen-Bereich:
$10.32
$10.84
52-Wochen-Spanne:
$8.635
$15.69
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Vergleichen Sie CERT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
10.52 | 1.70B | 405.76M | 7.98M | 77.47M | 0.05 |
|
VEEV
Veeva Systems Inc
|
271.08 | 44.26B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
76.88 | 13.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
68.63 | 12.83B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.99 | 6.49B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Using R and stats models for Certara Inc. forecastingQuarterly Portfolio Report & Consistent Growth Equity Picks - Newser
Leading vs lagging indicators on Certara Inc. performanceJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
What does recent volatility data suggest for Certara Inc.Chart Signals & Weekly High Return Stock Opportunities - Newser
Animal-free drug discovery is closer with QSP - MarketScreener
What to do if you’re stuck in Certara Inc.Quarterly Portfolio Summary & Intraday High Probability Alerts - Newser
Using data models to predict Certara Inc. stock movementJuly 2025 Technicals & Verified Entry Point Signals - Newser
Certara Incannounces availability of Pinnacle 21 Enterprise Plus - MarketScreener
Certara launches Pinnacle 21 Enterprise Plus solution - TipRanks
Certara Introduces Pinnacle 21 Enterprise Plus to Enhance Clinical Data Specification Management - Quiver Quantitative
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster - The Manila Times
Full technical analysis of Certara Inc. stockWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
50% Time Reduction: Certara's New Pinnacle 21 Platform Transforms Clinical Data Submission Process - Stock Titan
A Look At The Fair Value Of Certara, Inc. (NASDAQ:CERT) - simplywall.st
Market reaction to Certara Inc.’s recent newsWeekly Gains Report & Daily Oversold Bounce Ideas - Newser
Analyzing drawdowns of Certara Inc. with statistical toolsMarket Weekly Review & Weekly Top Stock Performers List - Newser
Analyzing Certara Inc. with multi timeframe chartsQuarterly Portfolio Summary & Community Consensus Trade Signals - Newser
What is Certara Inc.’s market positionMarket Risk Summary & Daily Stock Trend Reports - khodrobank.com
Certara Inc. stock trend forecast2025 Trading Recap & Low Risk High Reward Ideas - Newser
Visualizing Certara Inc. stock with heatmapsMarket Growth Summary & Safe Capital Investment Plans - Newser
Sector ETF performance correlation with Certara Inc.July 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Reversal indicators forming on Certara Inc. stockQuarterly Performance Summary & Daily Market Momentum Tracking - Newser
Certara Inc. recovery potential after sell off2025 Performance Recap & Technical Pattern Based Signals - Newser
How cyclical is Certara Inc.’s revenue streamJuly 2025 Chart Watch & Verified Stock Trade Ideas - khodrobank.com
Will Certara Inc. continue its uptrendJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Is Certara Inc.’s growth already priced inMarket Sentiment Summary & Expert Verified Stock Movement Alerts - khodrobank.com
Can Traders Expect Breakout From Certara Inc. This WeekJuly 2025 Price Swings & Weekly Momentum Picks - beatles.ru
Can Certara Inc. weather a recession2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - khodrobank.com
Global Drug Development Leader Certara Set for Back-to-Back Healthcare Conference Presentations - Stock Titan
Certara to Participate in Upcoming Investor Conferences - MarketScreener
Is Certara Inc. stock a good dividend stock2025 Major Catalysts & Intraday High Probability Setup Alerts - khodrobank.com
Published on: 2025-09-02 14:44:40 - Newser
Live Scanner Shows Breakout on Certara Inc.2025 Risk Factors & AI Driven Stock Reports - beatles.ru
Can Certara Inc. maintain sales growth2025 Winners & Losers & Intraday High Probability Alerts - khodrobank.com
A | Is Certara, Inc. being accumulated by smart moneyJuly 2025 WrapUp & Smart Money Movement Tracker - khodrobank.com
Is Certara Inc. stock risky to hold nowJuly 2025 WrapUp & Consistent Profit Trade Alerts - khodrobank.com
Is Certara Inc. being accumulated by smart money2025 Historical Comparison & Stepwise Trade Execution Plans - khodrobank.com
What’s the beta of Certara Inc. stockMarket Activity Summary & Precise Trade Entry Recommendations - khodrobank.com
Certara Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - 강소기업뉴스
Can swing trading help recover from Certara Inc. lossesWatch List & Weekly Breakout Stock Alerts - Newser
Gains Recap: Is Certara Inc.’s growth already priced inJuly 2025 Reactions & Smart Allocation Stock Tips - khodrobank.com
Candlestick signals on Certara Inc. stock today2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
Can momentum traders help lift Certara Inc.Trade Volume Report & Scalable Portfolio Growth Methods - Newser
How sensitive is Certara Inc. to inflationDollar Strength & Daily Momentum Trading Reports - خودرو بانک
Published on: 2025-09-01 03:29:55 - Newser
Can Certara Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - 강소기업뉴스
Ranking Certara Inc. among high performing stocks via toolsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Certara Inc-Aktie (CERT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
May 30 '25 |
Option Exercise |
0.00 |
22,828 |
0 |
20,530 |
| WALSH MATTHEW M | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
197,559 |
| Reynders John V W | Director |
May 21 '25 |
Option Exercise |
0.00 |
10,709 |
0 |
10,709 |
| Killefer Nancy | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
36,089 |
| Crane Rosemary A | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
29,915 |
| Collins Cynthia | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
36,089 |
| CASHMAN JAMES E III | Chairman |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
468,440 |
| BROSHY ERAN | Chairman |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
34,951 |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH |
Apr 01 '25 |
Option Exercise |
0.00 |
26,626 |
0 |
311,936 |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '25 |
Option Exercise |
0.00 |
26,626 |
0 |
127,669 |
0.11%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):